![Marianne T. Armstrong](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marianne T. Armstrong
Hoofd Techniek/Wetenschap/O&O bij INTERMUNE INC
Actieve functies van Marianne T. Armstrong
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
INTERMUNE INC | Hoofd Techniek/Wetenschap/O&O | 01-04-2002 | - |
Algemeen Adviseur | 01-04-2002 | - |
Loopbaan van Marianne T. Armstrong
Eerdere bekende functies van Marianne T. Armstrong
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Hoofd Techniek/Wetenschap/O&O | 01-12-1999 | 01-04-2002 |
Algemeen Adviseur | 01-12-1999 | 01-04-2002 | |
PathoGenesis Corp
![]() PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Hoofd Techniek/Wetenschap/O&O | 01-07-1998 | 01-11-1999 |
AMGEN INC. | Hoofd Techniek/Wetenschap/O&O | 01-05-1995 | 01-07-1998 |
Opleiding van Marianne T. Armstrong
Florida State University | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 6 |
Operationeel
Chief Tech/Sci/R&D Officer | 4 |
General Counsel | 2 |
Doctorate Degree | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
AMGEN INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
InterMune, Inc.
![]() InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
PathoGenesis Corp
![]() PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Health Technology |